Latest BioAlps news
News
AB2 Bio Secures $30 Million as Nippon Shinyaku Exercises US Commercialization Rights for Tadekinig Alfa
AB2 Bio, a Swiss Health Valley and EPFL based company, has announced that Nippon Shinyaku has exercised its exclusive option…
News
HeroSupport Starts Clinical Study With NYU Grossman School of Medicine
HeroSupport SA is a UNIGE and HUG spin out and created VENUS SHELL™ , a 3D-printed support that enables accurate,…
News
Impli and Molesense Selected for Germany’s SPRIND Continuous Hormone Monitoring Challenge
MoleSense and Impli, two startups based at Biopôle near Lausanne, have both been selected by Germany’s Federal Agency for Breakthrough…
News
Planimetrics Receives CHF 40,000 from Venture Kick
Planimetrics, formerly Laxiped, is a life-sciences project, spun out University of Geneva (UNIGE) and Assal Center, working on a solution…
News
Three Wins for the Swiss Health Valley: Recognition for Unboound, DIVERSSITY and Prof. Nicolas Winssinger
From clinical innovation to fundamental science, each of these Swiss Health Valley entrepreneurs and researchers were recognised at the highest…
News
Masimo Wins its Legal Battle Against Apple and is Set to Receive a Cheque for $634 million
Masimo, which has been headquartered in Neuchâtel since 2008 and employs over 100 staff there at the heart of the…
News
Givaudan and Nestlé: a Challenging First Semester for the two Swiss Health Valley Powerhouses
Two of Switzerland’s biggest names in industry unveiled their half-year results on Thursday, and the stock market did not respond…
News
Hilo Raises $19 Million and Launches Wearable Blood Pressure Monitor in the US
Hilo has launched Hilo Core, a wearable system designed to give people long-term blood pressure insights instead of one-off cuff…
News
Immitra Bio Closed a CHF 2.4 Million Pre-Seed Financing Round
The ETHZ spinoff and Geneva-based company aims to replace complex stem cell transplantation procedures with a single injection, making potentially…
News
Actival Secures CHF 1.4 Million Innosuisse Grant
Actival, the Neuchâtel-Based medtech startup spun off from CSEM, has been awarded a CHF 1.4 million grant from Innosuisse to…
News
UNDAE Opens Final Stage of Seed Funding Round
UNDAE, a University of Lausanne (UNIL) spinoff announces the opening of the final stage of its Seed funding round to…
News
Volv Global Puts AI at the Heart of Rare Disease Diagnosis
Volv Global, healthcare AI company headquartered at Biopôle Épalinges (Vaud – Switzerland), has released two significant pieces of work in…











